Selected article for: "cpe cytopathic effect and essential medium"
Author: Zeng, Zhengyang; Zhang, Runhong; Hong, Wei; Cheng, Yuting; Wang, Huijuan; Lang, Yange; Ji, Zhenglin; Wu, Yingliang; Li, Wenxin; Xie, Youli; Cao, Zhijian
Title: Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1
  • Document date: 2018_1_1
    • ID: zilqyfjl_72
    Snippet: HSV-1: Herpes simplex virus type 1; AMPs: antimicrobial peptides; CD spectroscopy: circular dichroism spectroscopy; PNS: peripheral nervous system; MAPK pathway: mitogen-activated protein kinase pathway; HNF4α: hepatocyte nuclear factor 4α; TFA: trifluoroacetic acid; HPLC: high performance liquid chromatography; MEM: minimum essential medium; FBS: fetal bovine serum; CPE: cytopathic effect; PBS: phosphate buffered saline; DMSO: dimethyl sulfoxi.....
    Document: HSV-1: Herpes simplex virus type 1; AMPs: antimicrobial peptides; CD spectroscopy: circular dichroism spectroscopy; PNS: peripheral nervous system; MAPK pathway: mitogen-activated protein kinase pathway; HNF4α: hepatocyte nuclear factor 4α; TFA: trifluoroacetic acid; HPLC: high performance liquid chromatography; MEM: minimum essential medium; FBS: fetal bovine serum; CPE: cytopathic effect; PBS: phosphate buffered saline; DMSO: dimethyl sulfoxide; HEPES: 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid; PFU: plaque-forming units; PRA: plaque reduction assay; MOI: multiplicity of infection; DAPI: 4',6-diamidino-2-phenylindole; FITC: fluorescein isothiocyanate; CC50: 50% cytotoxicity concentration; IC 50 : 50% inhibition concentration; SI: selecting index.

    Search related documents:
    Co phrase search for related documents
    • inhibition concentration and nervous system: 1, 2
    • liquid chromatography and MAPK pathway: 1, 2, 3
    • liquid chromatography and nervous system: 1, 2, 3, 4, 5, 6
    • liquid chromatography and nuclear factor: 1, 2, 3, 4, 5, 6
    • liquid chromatography and peripheral nervous system: 1
    • liquid chromatography and plaque reduction: 1
    • liquid chromatography and trifluoroacetic acid: 1
    • MAPK pathway and mitogen activate: 1, 2, 3, 4
    • MAPK pathway and nervous system: 1, 2
    • MAPK pathway and nuclear factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • MAPK pathway and plaque reduction: 1
    • minimum essential medium and plaque reduction: 1
    • mitogen activate and nuclear factor: 1
    • nervous system and nuclear factor: 1, 2, 3, 4, 5, 6, 7
    • nervous system and peripheral nervous system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • nervous system and plaque reduction: 1
    • nuclear factor and phosphate buffer saline: 1
    • nuclear factor and plaque reduction: 1
    • phosphate buffer saline and plaque reduction: 1, 2